Gut and Liver.2014;8(4):337-338.
Gut and Liver
2007 to Present ISSN: 1976-2283
Sort by
DISPLAY OPTIONS
Format:
Per page:
Gut and Liver.2014;8(4):335-336.
No abstract available.
Antiviral Agents/*administration & dosage ; Female ; Hepatitis C, Chronic/*drug therapy ; Humans ; Interferon-alpha/*administration & dosage ; Male ; Polyethylene Glycols/*administration & dosage ; Recombinant Proteins/administration & dosage ; Ribavirin/*administration & dosage
Antiviral Agents/*administration & dosage ; Female ; Hepatitis C, Chronic/*drug therapy ; Humans ; Interferon-alpha/*administration & dosage ; Male ; Polyethylene Glycols/*administration & dosage ; Recombinant Proteins/administration & dosage ; Ribavirin/*administration & dosage
Gut and Liver.2014;8(4):333-334.
No abstract available.
Behcet Syndrome/*radiography ; Female ; Humans ; Intestinal Diseases/*radiography ; Male
Behcet Syndrome/*radiography ; Female ; Humans ; Intestinal Diseases/*radiography ; Male
Gut and Liver.2009;3(3):218-221.
It is known that neutropenia caused by combination pegylated interferon plus ribavirin therapy for hepatitis C virus (HCV) infection is well tolerated and carries a negligible risk of infection. Neutropenic enterocolitis is encountered most frequently in patients with hemato-oncologic diseases who are undergoing intensive chemotherapy. However, little information exists regarding this life-threatening event in the setting of HCV therapy. We present here an unusual case of fatal neutropenic enterocolitis in a cirrhotic patient receiving combination therapy for HCV infection. This is the first report of a death from neutropenic enterocolitis associated with treatment for chronic HCV infection. The present case suggests that caution should be exercised when continuing HCV therapy in neutropenic patients with advanced fibrosis, and the decision to maintain such therapy should be balanced against the potential for serious adverse events.
Enterocolitis, Neutropenic ; Fibrosis ; Hepacivirus ; Hepatitis C ; Hepatitis C, Chronic ; Hepatitis, Chronic ; Humans ; Interferons ; Neutropenia ; Ribavirin
Enterocolitis, Neutropenic ; Fibrosis ; Hepacivirus ; Hepatitis C ; Hepatitis C, Chronic ; Hepatitis, Chronic ; Humans ; Interferons ; Neutropenia ; Ribavirin
Simultaneous Colonic Obstruction and Hydroureteronephrosis due to Mesenteric Fibromatosis.
Gut and Liver.2009;3(3):215-217.
Mesenteric fibromatosis (MF) is a rare benign mesenchymal lesion that can occur throughout the gastrointestinal tract, especially small bowel. Its biological behavior is intermediate between benign fibrous tissue proliferation and malignant fibrosarcoma. In previously reported cases of MF, we could find colonic obstruction or ureter obstruction, but simultaneous involvement of colon and ureter was not able to be seen. We described a patient that presented with colonic obstruction and hydroureteronephrosis due to MF at sigmoid colon which mimicked submucosal tumor such as gastrointestinal tumor. This case resulted in a positive positron emission tomography scan suggesting malignant neoplasm, but beta-catenin positivity on immunohistochemical staining separated MF from gastrointestinal stromal tumor and sclerosing mesenteritis. The clinical course of the patient was improved after surgical resection.
beta Catenin ; Colon ; Colon, Sigmoid ; Fibroma ; Fibrosarcoma ; Gastrointestinal Stromal Tumors ; Gastrointestinal Tract ; Humans ; Panniculitis, Peritoneal ; Positron-Emission Tomography ; Ureter
beta Catenin ; Colon ; Colon, Sigmoid ; Fibroma ; Fibrosarcoma ; Gastrointestinal Stromal Tumors ; Gastrointestinal Tract ; Humans ; Panniculitis, Peritoneal ; Positron-Emission Tomography ; Ureter
Gastric Metastasis from Ovarian Adenocarcinoma Presenting as a Submucosal Tumor without Ulceration.
Gut and Liver.2009;3(3):211-214.
Metastatic gastric cancer is extremely rare and gastric metastasis from ovarian adenocarcinoma has rarely been reported. All of the previously reported metastatic lesions presented as an ulcerative lesions. We report a case of 49-year-old woman in which gastric metastasis from ovarian adenocarcinoma presented as a submucosal tumor without ulceration on endoscopic examination. Gastrointestinal stromal tumor was suspected on endoscopic ultrasound (EUS) examination. It was confirmed histopathologically as metastatic ovarian adenocarcinoma after endoscopic submucosal dissection (ESD) with enucleation. Submucosal tumor of the stomach in patients with ovarian carcinoma should not be overlooked and ESD with enucleation may be a viable option when EUS with fine needle aspiration is not available.
Adenocarcinoma ; Biopsy, Fine-Needle ; Female ; Gastrointestinal Stromal Tumors ; Humans ; Middle Aged ; Neoplasm Metastasis ; Stomach ; Stomach Neoplasms ; Ulcer
Adenocarcinoma ; Biopsy, Fine-Needle ; Female ; Gastrointestinal Stromal Tumors ; Humans ; Middle Aged ; Neoplasm Metastasis ; Stomach ; Stomach Neoplasms ; Ulcer
Gut and Liver.2009;3(3):205-210.
BACKGROUND/AIMS: The protease inhibitors, nafamostat and gabexate, have been used to prevent pancreatitis related to endoscopic retrograde cholangiopancreatography (ERCP). In vitro, nafamostat inhibits the pancreatic protease activities 10-100 times more potently than gabexate. We evaluated the efficacy of nafamostat for prophylaxis against post-ERCP pancreatitis in comparison with gabexate. METHODS: Five hundred patients (208 patients in the nafamostat-treated group and 292 in the gabexate-treated group) were analyzed retrospectively after selective exclusion. The incidences of pancreatitis and hyperamylasemia after the ERCP were compared between the nafamostat and gabexate groups. RESULTS: The incidences of acute pancreatitis and hyperamylasemia were 9.1% and 40.9%, respectively, in the nafamostat-treated group, and 8.6% and 39.4% in the gabexate-treated group. The frequencies of post-ERCP pancreatitis and hyperamylasemia did not differ significantly between the two groups, Post-ERCP pancreatitis in two group did not vary according to the different ERCP procedures. The mean serum amylase level at 6 h after ERCP was significantly lower in the nafamostat-treated group than in the gabexate-treated group (p=0.020). However, the difference in serum amylase level did not persist at 18 h and 36 h post-ERCP. CONCLUSIONS: Administration of nafamostat before ERCP was not inferior to gabexate in protecting against the development of pancreatitis.
Amylases ; Cholangiopancreatography, Endoscopic Retrograde ; Gabexate ; Guanidines ; Humans ; Hyperamylasemia ; Incidence ; Pancreatitis ; Protease Inhibitors ; Retrospective Studies
Amylases ; Cholangiopancreatography, Endoscopic Retrograde ; Gabexate ; Guanidines ; Humans ; Hyperamylasemia ; Incidence ; Pancreatitis ; Protease Inhibitors ; Retrospective Studies
Gut and Liver.2009;3(3):197-204.
BACKGROUND/AIMS: Although early recognition and treatment with effective antibiotics have lead to improvements in the prognosis of patients with spontaneous bacterial peritonitis (SBP), it remains to be a serious complication in cirrhotic patients. This study was designed to evaluate the clinical manifestations and prognosis of patients with liver cirrhosis and SBP in Korea. METHODS: This was a multicenter retrospective study examining 157 episodes of SBP in 145 patients with cirrhosis. SBP was diagnosed based on a polymorphonuclear cell count in ascitic fluid of >250 cells/mm3 in the absence of data compatible with secondary peritonitis. RESULTS: The mean age of the cohort was 56 years, and 121 (77%) of the 157 episodes of SBP occurred in men. Microorganisms were isolated in 66 episodes (42%): Gram-negative bacteria in 54 (81.8%), Gram-positive in 11 (16.7%), and Candida in 1. Isolated Gram-negative organisms were resistant to third-generation cephalosporin in 6 cases (17%), to ciprofloxacin in 11 (20.8%), and to penicillin in 33 (62.3%). The treatment failure and in-hospital mortality rates were 12.1% and 21%, respectively. A high Model of End-Stage Liver Disease (MELD) score, SBP caused by extended-spectrum beta-lactamase-producing organisms, and hepatocellular carcinoma were independent prognostic factors of high in-hospital mortality. CONCLUSIONS: SBP remains to be a serious complication with high in-hospital mortality, especially in patients with a high MELD score.
Anti-Bacterial Agents ; Ascitic Fluid ; Candida ; Carcinoma, Hepatocellular ; Cell Count ; Ciprofloxacin ; Cohort Studies ; Fibrosis ; Gram-Negative Bacteria ; Hospital Mortality ; Humans ; Liver ; Liver Cirrhosis ; Liver Diseases ; Male ; Penicillins ; Peritonitis ; Prognosis ; Retrospective Studies ; Treatment Failure
Anti-Bacterial Agents ; Ascitic Fluid ; Candida ; Carcinoma, Hepatocellular ; Cell Count ; Ciprofloxacin ; Cohort Studies ; Fibrosis ; Gram-Negative Bacteria ; Hospital Mortality ; Humans ; Liver ; Liver Cirrhosis ; Liver Diseases ; Male ; Penicillins ; Peritonitis ; Prognosis ; Retrospective Studies ; Treatment Failure
Analysis of the Gastrointestinal Symptoms of Uninvestigated Dyspepsia and Irritable Bowel Syndrome.
Gut and Liver.2009;3(3):192-196.
BACKGROUND/AIMS: Epidemiological studies suggest that there is a considerable overlap between functional dyspepsia (FD) and irritable bowel syndrome (IBS). The aim of this study was to examine concurrent gastrointestinal symptoms in FD and IBS. METHODS: A total of 186 college students filled out a questionnaire regarding whether they had uninvestigated dyspepsia (UD, FD without endoscopic examination) and IBS based on Rome-II criteria. Gastrointestinal symptoms were measured using the Gastrointestinal Symptom Rating Scale (GSRS) questionnaire. RESULTS: A total of 181 students (98 males, mean age 24.6 years) completed both questionnaires. The prevalence of UD, IBS, and UD+IBS overlap was 12 (6.7%), 40 (22.1%), and 8 (4.4%), respectively. A significant UD+IBS overlap was observed (66.7% IBS in UD, 20.0% UD in IBS). Reflux scores of GSRS in either UD or IBS were significantly greater than in those without. Gastroesophageal reflux disease (GERD), defined as weekly occurring moderate symptoms of heartburn and/or acid regurgitation and evaluated using the GSRS, was found in 16 (8.8%) of the subjects. The prevalence of IBS was significantly higher in GERD patients than in non-GERD patients (50.0% vs 19.4%). CONCLUSIONS: The considerable overlap not only between UD and IBS, but also between GERD and IBS, suggests the involvement of common pathophysiological disturbances in the two conditions.
Dyspepsia ; Epidemiologic Studies ; Gastroesophageal Reflux ; Heartburn ; Humans ; Irritable Bowel Syndrome ; Male ; Prevalence ; Surveys and Questionnaires
Dyspepsia ; Epidemiologic Studies ; Gastroesophageal Reflux ; Heartburn ; Humans ; Irritable Bowel Syndrome ; Male ; Prevalence ; Surveys and Questionnaires
Gut and Liver.2009;3(3):186-191.
BACKGROUND/AIMS: Food residue is frequently observed in the gastric remnant after distal gastrectomy, despite adequate preparation. We devised a water-intake method to reduce food residue in the gastric remnant by drinking large quantities of water in a short time. The aims of this study were to identify the risk factors for food residue and to study the effectiveness of this new method for endoscopy preparation. METHODS: A cohort of 708 patients who underwent distal gastrectomy for gastric cancer was reviewed prospectively. Sixty patients with large amounts of food residue were randomly divided into two groups: a water-intake group (n=40) and a prolonged fasting group (n=20). RESULTS: The incidences of a large amount of food residue were 15.7%, 5.8%, 7.5%, and 2.8% at 3, 12, 24, and 36 months, respectively, after distal gastrectomy. Independent risk factors for food residue were endoscopy at 3 months, diabetes mellitus, a body mass index of <19.5, and laparoscopic surgery. The proportion of successful preparations at follow-up endoscopy was higher for the water-intake group (70%) than for the prolonged fasting group (40%, p=0.025). CONCLUSIONS: The water-intake method can be recommended as a preparation for endoscopy in patients who have had repetitive food residue or risk factors after distal gastrectomy.
Body Mass Index ; Cohort Studies ; Diabetes Mellitus ; Drinking ; Endoscopy ; Fasting ; Follow-Up Studies ; Gastrectomy ; Gastric Stump ; Humans ; Incidence ; Laparoscopy ; Prospective Studies ; Risk Factors ; Stomach Neoplasms
Body Mass Index ; Cohort Studies ; Diabetes Mellitus ; Drinking ; Endoscopy ; Fasting ; Follow-Up Studies ; Gastrectomy ; Gastric Stump ; Humans ; Incidence ; Laparoscopy ; Prospective Studies ; Risk Factors ; Stomach Neoplasms
Country
Republic of Korea
Publisher
Korean Society of Gastroenterology; Korean Society of Gastrointestinal Endoscopy; Korean Society of Neurogastroenterology and Motility; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Association for the Study of Intestinal Diseases; Korean Association for the Study of the Liver; Korean Pancreatobiliary Association; Korean Society of Gastrointestinal Cancer; Editorial Office of Gut and Liver
ElectronicLinks
http://www.gutnliver.org/Editor-in-chief
Young S. Kim
office@gutnliver.org
Abbreviation
Gut Liver
Vernacular Journal Title
ISSN
1976-2283
EISSN
2005-1212
Year Approved
2009
Current Indexing Status
Currently Indexed
Start Year
2007
Description
Gut and Liver is an international journal of gastroenterology with interests in the fields of gastrointestinal tract, liver, biliary tree, pancreas, motility and neurogastroenterology. Gut and Liver delivers up-to-dated, authoritative papers both in the clinic and research based areas in gastroenterology. The journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology.
Powered by IMICAMS(
备案号: 11010502037788, 京ICP备10218182号-8)